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Abstract  
Venous thromboembolism (VTE) is a serious but 
preventable complication of hospitalisation.  Doctors 
still sometimes fail to adhere to them, thus putting 
patients at risk and incurring considerable expense for 
the national health service.  We chose to audit the 
practice of doctors in our geriatric facility, and 
assessed the effect of a memoire to increase 
compliance.  We also explore how our hospitals can 
learn from the experience of other centres, where the 
risk of litigation has brought this condition to the 
forefront.  Compliance improved from 30.7% to 63.3%, 
which was statistically significant.  We would suggest 
that a centralised and organised approach could 
produce even greater levels of compliance. 
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Hospitalisation is known to be a particularly 
important risk factor for venous thromboembolism 
(VTE),
1,2,3,4
 and good clinical practice requires that all 
inpatients are risk-assessed repeatedly for 
predisposition to this disease.
5
 Medical patients are 
less likely to be adequately risk-assessed than other 
patients, despite accounting for the majority of 
reported cases of VTE.
1,3,6
  We wanted to investigate 
the level of compliance with guidelines in our geriatric 
facility, and whether we could improve it with simple 
measures to increase awareness.  
 
Method 
We used the guidelines by the Scottish 
Intercollegiate Network (SIGN) as our benchmark,
5,9
 
and data was collected by retrospective review of 
patient-notes. We included the first 40 patients 
discharged from hospital or deceased, starting from an 
arbitrary date. This value was chosen because it 
corresponded to 20% of the inpatient capacity at the 
time. Patients were only excluded if they were on 
anticoagulation or if their notes were irretrievable.  
Risks of thrombosis were considered high if patients 
had more than two risk factors for VTE, or if they 
were recovering from hip, knee or abdomino-pelvic 
surgery.  We noted the indications for prophylaxis, 
documentation of risk-assessment, preventative 
measures used and any contraindications.  For each 
case, we noted whether management followed 
guidelines as suggested by SIGN.  Since most patients 
are transferred from acute care, some were already on 
prophylaxis at the time of admission to our facility.  
We reported outcome as the proportion of patients 
adequately risk-assessed and treated.  
We designed a simple memoire on an A4-sheet to 
remind different members of the multidisciplinary 
team of the importance of risk-assessment (see figure 
1).  It included a list of the commoner risk factors, and 
was circulated to all wards and attached to patients’ 
treatment charts.  We then repeated our audit a few 
months later and compared the outcomes. 
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Figure 1: Reproduction of the proforma used for the 
purpose of the audit 
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Ethics 
The need for individual informed consent was waived 
because this was a retrospective analysis of the routine care 
of patients, and there was no breach of privacy or anonymity. 
 
Results 
The characteristics of the two populations are outlined 
in table 1. In the first arm, compliance was found to be only 
30.7% (95% confidence interval 12.4% - 60.0%).  This had  
improved to 63.3% in the second arm (95% confidence 
interval 45.5% - 78.2%). This difference was found to be 
statistically significant (one-tailed p value 0.02).  Medical 
patients formed the largest single group in both arms, 
although there were more surgical and orthopaedic patients 
in the second part of our audit (table 1).  The most common 
risk factors in our patients were immobility, active medical 
disease and obesity, and the most common active medical 
conditions listed were sepsis and pulmonary oedema.  
 
Discussion 
VTE prophylaxis is known to efficacious, safe 
and cost-effective.
7-8
 Our audit suggests that a lot more 
needs to be done to improve compliance with 
guidelines.  However, we also find the outcome 
encouraging, as it suggests that simple measures can 
greatly improve the level of care we provide.  The 
main limitations of our audit are its small size and its 
retrospective approach.  It was not powered to answer 
detailed questions about how we use VTE prophylaxis. 
During the same time period, an admission proforma 
was implemented at the main acute facility including a 
reminder to risk-assess patients for VTE, and may 
have contributed to our results. The larger number of 
orthopoaedic patients in the second part of our audit 
may also have contributed to the increase in 
compliance seen. 
We can’t overemphasise the importance of 
documentation – both of indications and 
contraindications for VTE, and of any patient 
preferences that influence clinical decisions. Simple 
measures, like hydration and early mobilisation, 
should be implemented generally for all patients.
9 
 
Conclusion 
We should be guided by the experience of other 
centres, which have achieved excellent results using a 
variety of simple measures, regular re-audit and individual 
feedback.
4
 We would particularly recommend making better 
use of our IT system which can be a powerful way to 
prompt staff to think of VTE.
4
 We can also implement the 
same strategy in other areas of concern in patient 
management. 
 
 
 
 
 
 
 
Table I : A comparison between the two legs of the audit,  
outlining patient characteristics and results. 
*
Primary admission:  for those patients transferred 
from other centres, refers to the reason for requiring 
acute care. 
#
Risk factors cited: active medical conditions (e.g. 
heart failure, sepsis, acute coronary syndromes, NMS), 
active malignancy, decreased mobility (including 
stroke), obesity, previous VTE. 
 
 
 1
st
 leg of audit 2
nd
 leg of audit 
Number of patients 
included 
38 40 
Number of patients 
excluded 
4 2 
   
Males (%) 17 (44.7%) 17 (42.5%) 
Age 60 (%) 0 (0%) 1 (2.5%) 
Age 61-70 (%) 2 (5.3%) 2 (5.0%) 
Age 71-80 (%) 16 (42.1%)
  
17 (42.5%) 
Age 81-90 (%) 18 (47.4%) 17 (42.5%) 
Age >90 (%) 2 (5.3%) 3 (7.5%) 
 
  
Reasons for 
primary admission
* 
  
Medical 24 (63.2%) 17 (42.5%) 
Surgical  2 (5.3%) 5 (12.5%) 
Orthopaedic 4 (10.5%) 15 (37.5%) 
Other 
(neurosurgery, 
rehabilitation, 
social issues) 
8 (21.1%) 3 (7.5%) 
   
DVT prophylaxis 
at time of referral 
7 (18.4%) 17 (42.5%) 
Prophylaxis 
indicated at any 
time during 
admission
# 
13 (34.2%)
  
30 (75%) 
Prophylaxis 
appropriately 
administered 
4/13 (30.7%) 19/30 (63.3%) 
30
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